These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida. Toepoel M, Steegers-Theunissen RP, Ouborg NJ, Franke B, González-Zuloeta Ladd AM, Joosten PH, van Zoelen EJ. Birth Defects Res A Clin Mol Teratol; 2009 Jul 15; 85(7):629-36. PubMed ID: 19215021 [Abstract] [Full Text] [Related]
8. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects. Lancet; 1979 Sep 29; 2(8144):651-62. PubMed ID: 90757 [Abstract] [Full Text] [Related]
9. Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida. Talabani H, Dreux S, Luton D, Simon-Bouy B, Le Fiblec B, Col JY, Guibourdenche J, Oury JF, Muller F. Pediatr Res; 2005 Oct 29; 58(4):766-70. PubMed ID: 16189207 [Abstract] [Full Text] [Related]
14. Protein measurements in the early prenatal diagnosis of spina bifida. Brock DJ. Hum Hered; 1976 Oct 29; 26(6):401-8. PubMed ID: 64448 [Abstract] [Full Text] [Related]